Despite 12 Deaths During Clinical Trials, CDC Signs Off on RSV Shots for Newborns

Despite 12 Deaths During Clinical Trials, CDC Signs Off on RSV Shots for Newborns

Medical experts criticized the Centers for Disease Control and Prevention’s Thursday decision to recommend a…

Children's Health Defense

Medical experts criticized the Centers for Disease Control and Prevention’s Thursday decision to recommend a “new immunization” for newborns to protect against respiratory syncytial virus, or RSV, calling the move unnecessary and not worth the known risks.

By Michael Nevradakis, Ph.D.

The Centers for Disease Control and Prevention (CDC) on Thursday recommended the first-ever monoclonal antibody marketed as a defense for all newborns against respiratory syncytial virus, or RSV.

Beyfortus, also known as nirsevimab, is produced by pharma giants Sanofi and AstraZeneca.

Read Full Article Here…(childrenshealthdefense.org)

Home | Caravan to Midnight (zutalk.com)

Live Stream + Chat (zutalk.com)

We Need Your Help to Keep Caravan To Midnight Going,

Please Consider Donating to Help Keep Independent Media Independent